108 related articles for article (PubMed ID: 18483319)
1. Inhibition of DNA binding of the NF-Y transcription factor by the pyrrolobenzodiazepine-polyamide conjugate GWL-78.
Kotecha M; Kluza J; Wells G; O'Hare CC; Forni C; Mantovani R; Howard PW; Morris P; Thurston DE; Hartley JA; Hochhauser D
Mol Cancer Ther; 2008 May; 7(5):1319-28. PubMed ID: 18483319
[TBL] [Abstract][Full Text] [Related]
2. Modulation of topoisomerase IIα expression and chemosensitivity through targeted inhibition of NF-Y:DNA binding by a diamino p-anisyl-benzimidazole (Hx) polyamide.
Pett L; Kiakos K; Satam V; Patil P; Laughlin-Toth S; Gregory M; Bowerman M; Olson K; Savagian M; Lee M; Lee M; Wilson WD; Hochhauser D; Hartley JA
Biochim Biophys Acta Gene Regul Mech; 2017 May; 1860(5):617-629. PubMed ID: 27750031
[TBL] [Abstract][Full Text] [Related]
3. Nuclear factor-Y binding to the topoisomerase IIalpha promoter is inhibited by both the p53 tumor suppressor and anticancer drugs.
Joshi AA; Wu Z; Reed RF; Suttle DP
Mol Pharmacol; 2003 Feb; 63(2):359-67. PubMed ID: 12527807
[TBL] [Abstract][Full Text] [Related]
4. Modulation of topoisomerase IIalpha expression by a DNA sequence-specific polyamide.
Hochhauser D; Kotecha M; O'hare C; Morris PJ; Hartley JM; Taherbhai Z; Harris D; Forni C; Mantovani R; Lee M; Hartley JA
Mol Cancer Ther; 2007 Jan; 6(1):346-54. PubMed ID: 17237293
[TBL] [Abstract][Full Text] [Related]
5. Targeting the inverted CCAAT Box-2 of the topoisomerase IIalpha gene: DNA sequence selective recognition by a polyamide-intercalator as a staggered dimer.
Mackay H; Brown T; Sexton JS; Kotecha M; Nguyen B; Wilson WD; Kluza J; Savic B; O'Hare C; Hochhauser D; Lee M; Hartley JA
Bioorg Med Chem; 2008 Feb; 16(4):2093-102. PubMed ID: 17977733
[TBL] [Abstract][Full Text] [Related]
6. CBF/NF-Y functions both in nucleosomal disruption and transcription activation of the chromatin-assembled topoisomerase IIalpha promoter. Transcription activation by CBF/NF-Y in chromatin is dependent on the promoter structure.
Coustry F; Hu Q; de Crombrugghe B; Maity SN
J Biol Chem; 2001 Nov; 276(44):40621-30. PubMed ID: 11514576
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the human topoisomerase IIbeta (TOP2B) promoter activity: essential roles of the nuclear factor-Y (NF-Y)- and specificity protein-1 (Sp1)-binding sites.
Lok CN; Lang AJ; Mirski SE; Cole SP
Biochem J; 2002 Dec; 368(Pt 3):741-51. PubMed ID: 12197834
[TBL] [Abstract][Full Text] [Related]
8. Modulation of DNA topoisomerase II alpha promoter activity by members of the Sp (specificity protein) and NF-Y (nuclear factor Y) families of transcription factors.
Magan N; Szremska AP; Isaacs RJ; Stowell KM
Biochem J; 2003 Sep; 374(Pt 3):723-9. PubMed ID: 12769819
[TBL] [Abstract][Full Text] [Related]
9. Cell-cycle regulation of the DNA topoisomerase IIalpha promoter is mediated by proximal CCAAT boxes: possible involvement of acetylation.
Adachi N; Nomoto M; Kohno K; Koyama H
Gene; 2000 Mar; 245(1):49-57. PubMed ID: 10713444
[TBL] [Abstract][Full Text] [Related]
10. CCAAT binding factor (CBF) binding mediates cell cycle activation of topoisomerase IIalpha. Conventional CBF activation domains are not required.
Hu Q; Bhattacharya C; Maity SN
J Biol Chem; 2002 Oct; 277(40):37191-200. PubMed ID: 12149265
[TBL] [Abstract][Full Text] [Related]
11. An extended pyrrolobenzodiazepine-polyamide conjugate with selectivity for a DNA sequence containing the ICB2 transcription factor binding site.
Brucoli F; Hawkins RM; James CH; Jackson PJ; Wells G; Jenkins TC; Ellis T; Kotecha M; Hochhauser D; Hartley JA; Howard PW; Thurston DE
J Med Chem; 2013 Aug; 56(16):6339-51. PubMed ID: 23889553
[TBL] [Abstract][Full Text] [Related]
12. ATF is important to late S phase-dependent regulation of DNA topoisomerase IIalpha gene expression in HeLa cells.
Son MY; Kim TJ; Kweon KI; Park JI; Park C; Lee YC; No Z; Ahn JW; Yoon WH; Park SK; Lim K; Hwang BD
Cancer Lett; 2002 Oct; 184(1):81-8. PubMed ID: 12104051
[TBL] [Abstract][Full Text] [Related]
13. Novel C8-linked pyrrolobenzodiazepine (PBD)-heterocycle conjugates that recognize DNA sequences containing an inverted CCAAT box.
Brucoli F; Hawkins RM; James CH; Wells G; Jenkins TC; Ellis T; Hartley JA; Howard PW; Thurston DE
Bioorg Med Chem Lett; 2011 Jun; 21(12):3780-3. PubMed ID: 21570842
[TBL] [Abstract][Full Text] [Related]
14. HMGB1 and HMGB2 proteins up-regulate cellular expression of human topoisomerase IIalpha.
Stros M; Polanská E; Struncová S; Pospísilová S
Nucleic Acids Res; 2009 Apr; 37(7):2070-86. PubMed ID: 19223331
[TBL] [Abstract][Full Text] [Related]
15. Targeting the inverted CCAAT box 2 in the topoisomerase IIalpha promoter by JH-37, an imidazole-pyrrole polyamide hairpin: design, synthesis, molecular biology, and biophysical studies.
Henry JA; Le NM; Nguyen B; Howard CM; Bailey SL; Horick SM; Buchmueller KL; Kotecha M; Hochhauser D; Hartley JA; Wilson WD; Lee M
Biochemistry; 2004 Sep; 43(38):12249-57. PubMed ID: 15379563
[TBL] [Abstract][Full Text] [Related]
16. The CCAAT box binding transcription factor, nuclear factor-Y (NF-Y) regulates transcription of human aldo-keto reductase 1C1 (AKR1C1) gene.
Pallai R; Simpkins H; Chen J; Parekh HK
Gene; 2010 Jul; 459(1-2):11-23. PubMed ID: 20338228
[TBL] [Abstract][Full Text] [Related]
17. Expression of the Op18 gene is maintained by the CCAAT-binding transcription factor NF-Y.
Benlhabib H; Herrera JE
Gene; 2006 Aug; 377():177-85. PubMed ID: 16757134
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional regulation of topoisomerase II alpha at confluence and pharmacological modulation of expression by bis-benzimidazole drugs.
Tolner B; Hartley JA; Hochhauser D
Mol Pharmacol; 2001 Apr; 59(4):699-706. PubMed ID: 11259613
[TBL] [Abstract][Full Text] [Related]
19. Nuclear Localization and Gene Expression Modulation by a Fluorescent Sequence-Selective p-Anisyl-benzimidazolecarboxamido Imidazole-Pyrrole Polyamide.
Kiakos K; Pett L; Satam V; Patil P; Hochhauser D; Lee M; Hartley JA
Chem Biol; 2015 Jul; 22(7):862-75. PubMed ID: 26119998
[TBL] [Abstract][Full Text] [Related]
20. Novel regulation of nuclear factor-YB by miR-485-3p affects the expression of DNA topoisomerase IIα and drug responsiveness.
Chen CF; He X; Arslan AD; Mo YY; Reinhold WC; Pommier Y; Beck WT
Mol Pharmacol; 2011 Apr; 79(4):735-41. PubMed ID: 21252292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]